[National breast cancer brachytherapy survey in France: Results and perspectives in 2009]
Fiche publication
Date publication
juin 2010
Auteurs
Membres identifiés du Cancéropôle Est :
Pr PEIFFERT Didier, Pr TRUC Gilles
Tous les auteurs :
Hannoun-Levi JM, Hennequin C, Pommier P, Izar F, Thomas L, Le Scodan R, Lesaunier F, Nguyen T, Heymann S, Truc G, Peiffert D
Lien Pubmed
Résumé
PURPOSE: To present the national survey patterns in France for breast cancer brachytherapy in 2009. MATERIAL AND METHOD: A written questionnaire was sent to the academic and general hospitals and the anticancer centres. The different items were type of institution; breast cancer clinical trial participation; number of breast brachytherapy per year; its indications; material and dose rate used. RESULTS: Among the 76 sent questionnaires, 35 (46 %) answers were available: 9 % of academic hospitals and 50 % of cancer centres performed breast brachytherapy. The number of breast brachytherapy per year ranged between 300 and 350. The indications were boost (100 %), partial breast irradiation (20 %) and second conservative treatment for local recurrence (53 %). The implanted material consisted in needles (27 %) and plastic tubes (73 %). The dose rate was low (50 %), pulsed (25 %) and high (25 %). CONCLUSION: Breast brachytherapy appears as a validated technique in case of boost but remains under investigation for partial breast irradiation and second conservative treatments. Good clinical practice rules as well as technical and dosimetric guidelines are needed. A cost-effective analysis of breast brachytherapy is warranted.
Référence
Cancer Radiother. 2010 Jun;14(3):176-82